10/18/2024 2:18:17 PM The heart attack gender gap: women remain under-represented in clinical research about heart disease By Ella Tunnell According to the British Heart Foundation, a woman is 50% more likely than a man to receive the wrong initial diagnosis for a heart...
7/12/2024 2:03:05 PM New guidance from the MHRA on medical devices that use machine learning By Jeremy Kelly George Harrington Artificial Intelligence promises a range of practical applications to improve efficiencies within the medical sector; in particular, the...
6/27/2024 12:17:27 PM UK MHRA's intention to accept medical devices approved by international regulators By Georgie Barrow On 21 May 2024, the UK Medicines and Healthcare products Regulation Agency (MHRA) issued a statement of policy intent describing a...
11/28/2023 7:00:43 PM Investment community gives the UK a vote of confidence By Dean Outten Yesterday, the government announced that the UK has secured commitment from the world’s leading investors of nearly £30bn. The...
8/9/2023 11:22:45 AM All at CE? "Indefinite" delay to UKCA requirements in certain sectors By Gustaf Duhs The UK government has had significant issues with the implementation the UK’s post-Brexit products safety conformity mark, the UKCA mark,...
5/3/2023 4:21:29 PM Proposed overhaul of clinical research delivery in the UK By Elizabeth Pistak During Covid-19, UK clinical research was very much at the front and centre of the global effort to find a vaccine. As we started to...
6/10/2022 6:01:03 AM No protected costs position for the CMA By Gustaf Duhs On 25 May 2022, the Supreme Court (UKSC) overturned the Court of Appeal’s costs ruling in the Pfizer/Flynn case regarding excessive...
4/13/2022 1:59:24 PM Definition of excessive pricing in pharma cases re-tweaked? By Gustaf Duhs The CMA’s full text decision in the long-running Hydrocortisone case, originally initiated in 2016 and in which the CMA imposed record...